MichaelHowardBlochMD

Clinical Trials

• N-Acetylcysteine for Pediatric Trichotillomania Start of enrollment: 2009 Oct 01

  Completed

  Phase 2

• N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder Start of enrollment: 2012 Jul 01

  Completed

  Phase 2

• N-acetylcysteine (NAC) for Children With Tourette Syndrome Start of enrollment: 2010 Jul 01

  Completed

  Phase 2

• Ketamine Infusion for Obsessive-Compulsive Disorder Start of enrollment: 2009 Feb 01

  Completed

  Phase 2

• Ketamine Infusion for Social Anxiety Disorder Start of enrollment: 2015 Jan 02

  Completed

  Early Phase 1

• FAAH Inhibitor Trial for Adults With Tourette Syndrome Start of enrollment: 2014 May 01

  Terminated

  Phase 1

• Ketamine Infusion for Adolescent Depression and Anxiety Start of enrollment: 2015 Oct 01

  Completed

  Phase 4

• Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder Start of enrollment: 2017 Jan 01

  Completed

  Phase 2, Phase 3

• A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette Syndrome Start of enrollment: 2022 May 01

  Not yet recruiting

  Not Applicable

  Roles: Principal Investigator, Contact

• Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults Start of enrollment: 2023 Oct 01

  Recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine Start of enrollment: 2022 Jan 21

  Recruiting

  Phase 2

  Roles: Principal Investigator

• Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette Syndrome Start of enrollment: 2022 Mar 01

  Not yet recruiting

  Not Applicable

  Roles: Principal Investigator, Contact

• Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults Start of enrollment: 2023 Jan 31

  Recruiting

  Phase 3

  Roles: Contact

• A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder Start of enrollment: 2023 Aug 16

  Recruiting

  Phase 3

  Roles: Contact

• Join now to see all